168 related articles for article (PubMed ID: 35930870)
1. Generation of an induced pluripotent stem cell line (DHMCi009-A) from an individual with TUBB2A tubulinopathy.
Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
Stem Cell Res; 2022 Oct; 64():102879. PubMed ID: 35930870
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line (DHMCi008-A) from an individual with TUBA1A tubulinopathy.
Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
Stem Cell Res; 2022 Jul; 62():102818. PubMed ID: 35636247
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
[TBL] [Abstract][Full Text] [Related]
5. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
[TBL] [Abstract][Full Text] [Related]
6. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
[TBL] [Abstract][Full Text] [Related]
9. Generation of induced pluripotent stem cell line (FMCPGHi001-A) from a 25-year-old Chinese Han healthy male donor.
Wang T; Tang W; Zeng Q; Miao S; Pi C; Li Y; Yue W; Yu S
Stem Cell Res; 2022 Apr; 60():102735. PubMed ID: 35247846
[TBL] [Abstract][Full Text] [Related]
10. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human induced pluripotent stem cell (iPSC) SZGJMSi004-A line from a 28-year-old Han male patient with depression.
Yin X; Cai Y; Jia N; Hui L; Zhu Z
Stem Cell Res; 2024 Jun; 77():103428. PubMed ID: 38696853
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived stem cell line UKMi005-A (hiPSC) harboring a non-synonymous heterozygous KCNJ5 gene variant.
Kayser A; Dittmann S; van Impel A; Šarić T; Schulze-Bahr E
Stem Cell Res; 2023 Dec; 73():103223. PubMed ID: 37890333
[TBL] [Abstract][Full Text] [Related]
13. Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells.
Ahmed E; Fieldès M; Bourguignon C; Mianné J; Petit A; Amel N; Foisset F; Bourdais C; Vachier I; Assou S; De Vos J; Bourdin A
Stem Cell Res; 2024 Jun; 77():103437. PubMed ID: 38723411
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease.
Zhang M; Yu M; Guo R; Zhang Y; Zhang X; Sun J; Zhang J; Wang X; Ma J
Stem Cell Res; 2023 Jun; 69():103116. PubMed ID: 37178573
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
18. Generation of human-induced pluripotent stem cell line from PBMC of healthy donor using integration-free Sendai virus technology.
Sarkar J; Dhepe S; Shivalkar A; Kuhikar R; More S; Konala VBR; Bhanushali P; Khanna A
Stem Cell Res; 2024 Jun; 77():103402. PubMed ID: 38547666
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
Zhang Y; Li A; Huang CL; Wang G; Wang D
Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
